NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Wendy R Parulekar
Queen's University Kingston - Kingston / Canada
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 644972
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Wendy R Parulekar's MOST POPULAR ARTICLES
1-)
SPIRIT 2013 statement: defining standard protocol items for clinical trialsAW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ...Annals of internal medicine 158 (3), 200-207, 201346592013
2-)
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsAW Chan, JM Tetzlaff, PC Gøtzsche, DG Altman, H Mann, JA Berlin, ...Bmj 346, 201349452013
3-)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical …MJ Moore, D Goldstein, J Hamm, A Figer, JR Hecht, S Gallinger, HJ Au, ...Journal of clinical oncology 25 (15), 1960-1966, 200748682007
4-)
Enzalutamide with standard first-line therapy in metastatic prostate cancerID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ...New England Journal of Medicine 381 (2), 121-131, 201914062019
5-)
Regional nodal irradiation in early-stage breast cancerTJ Whelan, IA Olivotto, WR Parulekar, I Ackerman, BH Chua, A Nabid, ...New England Journal of Medicine 373 (4), 307-316, 201513512015
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept